OXAZEPAM
Generic: OXAZEPAM
Actavis PharmaManufacturer
ORALRoute
OXAZEPAMActive Substance
1988-04-14Original Approval
OXAZEPAM is FDA application ANDA072253, sponsored by ACTAVIS ELIZABETH. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
TOXICITY TO VARIOUS AGENTS
3,051 reports
2
DRUG ABUSE
1,553 reports
3
FALL
1,545 reports
4
HYPOTENSION
1,448 reports
5
DRUG INTERACTION
1,238 reports
6
COMA
1,163 reports
7
SOMNOLENCE
1,033 reports
8
DEPRESSED LEVEL OF CONSCIOUSNESS
964 reports
9
PAIN
920 reports
10
CONSTIPATION
872 reports